DXCM
Price
$85.33
Change
+$1.96 (+2.35%)
Updated
Jul 14 closing price
Capitalization
53.47B
15 days until earnings call
ISRG
Price
$516.44
Change
+$4.38 (+0.86%)
Updated
Jul 14 closing price
Capitalization
141.46B
7 days until earnings call
Interact to see
Advertisement

DXCM vs ISRG

Header iconDXCM vs ISRG Comparison
Open Charts DXCM vs ISRGBanner chart's image
DexCom
Price$85.33
Change+$1.96 (+2.35%)
Volume$2.38M
Capitalization53.47B
Intuitive Surgical
Price$516.44
Change+$4.38 (+0.86%)
Volume$2.08M
Capitalization141.46B
DXCM vs ISRG Comparison Chart in %
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. ISRG commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and ISRG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (DXCM: $85.33 vs. ISRG: $516.44)
Brand notoriety: DXCM: Not notable vs. ISRG: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 75% vs. ISRG: 134%
Market capitalization -- DXCM: $53.47B vs. ISRG: $141.46B
DXCM [@Medical Specialties] is valued at $53.47B. ISRG’s [@Medical Specialties] market capitalization is $141.46B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 0 FA rating(s) are green whileISRG’s FA Score has 1 green FA rating(s).

  • DXCM’s FA Score: 0 green, 5 red.
  • ISRG’s FA Score: 1 green, 4 red.
According to our system of comparison, ISRG is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 5 TA indicator(s) are bullish while ISRG’s TA Score has 4 bullish TA indicator(s).

  • DXCM’s TA Score: 5 bullish, 4 bearish.
  • ISRG’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, DXCM is a better buy in the short-term than ISRG.

Price Growth

DXCM (@Medical Specialties) experienced а +2.88% price change this week, while ISRG (@Medical Specialties) price change was -3.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.46%. For the same industry, the average monthly price growth was +2.75%, and the average quarterly price growth was -0.13%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 23, 2025.

ISRG is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Medical Specialties (+1.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ISRG($141B) has a higher market cap than DXCM($53.5B). DXCM has higher P/E ratio than ISRG: DXCM (106.11) vs ISRG (78.50). DXCM YTD gains are higher at: 9.721 vs. ISRG (-1.058). ISRG has higher annual earnings (EBITDA): 2.19B vs. DXCM (917M). ISRG has more cash in the bank: 5.22B vs. DXCM (2.72B). ISRG has higher revenues than DXCM: ISRG (7.12B) vs DXCM (3.62B).
DXCMISRGDXCM / ISRG
Capitalization53.5B141B38%
EBITDA917M2.19B42%
Gain YTD9.721-1.058-919%
P/E Ratio106.1178.50135%
Revenue3.62B7.12B51%
Total Cash2.72B5.22B52%
Total Debt2.59BN/A-
FUNDAMENTALS RATINGS
DXCM vs ISRG: Fundamental Ratings
DXCM
ISRG
OUTLOOK RATING
1..100
1158
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
10023
SMR RATING
1..100
4153
PRICE GROWTH RATING
1..100
5357
P/E GROWTH RATING
1..100
6958
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (84) in the Medical Specialties industry is in the same range as ISRG (88). This means that DXCM’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's Profit vs Risk Rating (23) in the Medical Specialties industry is significantly better than the same rating for DXCM (100). This means that ISRG’s stock grew significantly faster than DXCM’s over the last 12 months.

DXCM's SMR Rating (41) in the Medical Specialties industry is in the same range as ISRG (53). This means that DXCM’s stock grew similarly to ISRG’s over the last 12 months.

DXCM's Price Growth Rating (53) in the Medical Specialties industry is in the same range as ISRG (57). This means that DXCM’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's P/E Growth Rating (58) in the Medical Specialties industry is in the same range as DXCM (69). This means that ISRG’s stock grew similarly to DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMISRG
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 23 days ago
72%
Bearish Trend 5 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
47%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDNI32.960.28
+0.85%
First Trust Dow Jones Intl Intnt ETF
VYMI80.590.09
+0.11%
Vanguard Intl Hi Div Yld Idx ETF
SIXJ32.150.02
+0.06%
AllianzIM US Lrg Cp 6M Bfr10 Jan/Jul ETF
QSIG48.630.01
+0.01%
WisdomTree US Shrt-Term Corp Bd
DDWM39.83-0.03
-0.08%
WisdomTree Dynamic International Eq ETF

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+2.35%
CERS - DXCM
42%
Loosely correlated
N/A
RMD - DXCM
35%
Loosely correlated
-0.11%
IRMD - DXCM
34%
Loosely correlated
+0.87%
PEN - DXCM
34%
Loosely correlated
+0.58%
ACRS - DXCM
33%
Loosely correlated
+0.64%
More

ISRG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISRG
1D Price
Change %
ISRG100%
+0.86%
BSX - ISRG
73%
Closely correlated
+1.09%
SYK - ISRG
66%
Closely correlated
+0.51%
NTRA - ISRG
56%
Loosely correlated
-1.40%
MMSI - ISRG
55%
Loosely correlated
-0.04%
GKOS - ISRG
47%
Loosely correlated
+0.37%
More